Combining GLP-1 and glucagon for the treatment of obesity and diabetes

被引：0
|
作者：
Idris, Iskandar [1 ]
机构：
[1] Univ Nottingham, Nottingham NG7 2RD, England
来源：
DIABETES OBESITY & METABOLISM | 2013年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：481 / 482
页数：2
相关论文
共 50 条
  • [31] A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
    Day, Jonathan W.
    Ottaway, Nickki
    Patterson, James T.
    Gelfanov, Vasily
    Smiley, David
    Gidda, Jas
    Findeisen, Hannes
    Bruemmer, Dennis
    Drucker, Daniel J.
    Chaudhary, Nilika
    Holland, Jenna
    Hembree, Jazzminn
    Abplanalp, William
    Grant, Erin
    Ruehl, Jennifer
    Wilson, Hilary
    Kirchner, Henriette
    Lockie, Sarah Haas
    Hofmann, Susanna
    Woods, Stephen C.
    Nogueiras, Ruben
    Pfluger, Paul T.
    Perez-Tilve, Diego
    DiMarchi, Richard
    Tschoep, Matthias H.
    NATURE CHEMICAL BIOLOGY, 2009, 5 (10) : 749 - 757
  • [32] A Novel Glucagon/GLP-1 Co-Agonist Eliminates Obesity in Rodents
    Tschoep, Matthias H.
    Ottaway, Nickki
    Perez-Tilve, Diego
    Pfluger, Paul T.
    Nogueiras, Ruben
    Chaudhary, Nilika
    Holland, Jenna
    Hembree, Jazzminn
    Abplanalp, William
    Grant, Erin
    Ruehl, Jennifer
    Wilson, Hilary
    Kirchner, Henriette
    Lockie, Sarah
    Hofmann, Susanna
    Findeisen, Hannes
    Bruemmer, Dennis
    Gidda, Jas
    Day, Jon
    Smiley, David
    Gelfanov, Vasily
    Dimarchi, Richard
    DIABETES, 2009, 58 : A83 - A83
  • [33] Newer GLP-1 receptor agonists and obesity-diabetes
    Brown, Emily
    Cuthbertson, Daniel J.
    Wilding, John P.
    PEPTIDES, 2018, 100 : 61 - 67
  • [34] Healthcare Professionals' Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors
    Garvey, W. Timothy
    Mahle, Cathy D.
    Kushner, Robert F.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
  • [35] Healthcare Professionals' Perceptions of Obesity & Agonists of the Glucagon, GLP-1 and GIP Receptors
    Garvey, W. Timothy
    Mahle, Cathy
    Kushner, Robert
    OBESITY, 2023, 31 : 106 - 106
  • [36] A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
    Jonathan W Day
    Nickki Ottaway
    James T Patterson
    Vasily Gelfanov
    David Smiley
    Jas Gidda
    Hannes Findeisen
    Dennis Bruemmer
    Daniel J Drucker
    Nilika Chaudhary
    Jenna Holland
    Jazzminn Hembree
    William Abplanalp
    Erin Grant
    Jennifer Ruehl
    Hilary Wilson
    Henriette Kirchner
    Sarah Haas Lockie
    Susanna Hofmann
    Stephen C Woods
    Ruben Nogueiras
    Paul T Pfluger
    Diego Perez-Tilve
    Richard DiMarchi
    Matthias H Tschöp
    Nature Chemical Biology, 2009, 5 : 749 - 757
  • [37] GLP-1 Agonists for Obesity
    Moran, Alyssa J.
    Roberto, Christina A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (08):
  • [38] Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment
    Trapp, Stefan
    Brierley, Daniel, I
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 557 - 570
  • [39] Obesity and GLP-1 RAs
    Bright, Tamis
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 1 - 2
  • [40] Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes
    Chen, Xinyu
    Fu, Junjie
    Zhou, Feng
    Yang, Qimeng
    Wang, Jialing
    Feng, Hui
    Jiang, Wen
    Jin, Luofan
    Tang, Xuelin
    Jiang, Neng
    Yin, Jian
    Han, Jing
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (21) : 12595 - 12613
12345